In breast cancer, MTSS1 interacts with the E3 ligase RBCK1, enhancing RBCK1-mediated ubiquitination and degradation of p65, thereby inhibiting the NF-κB signaling pathway that is essential for the self-renewal of TICs. Here, MTSS1 is linked to breast carcinoma.